In human cancers, human CD25 is mainly expressed on CD4+FoxP3+ Treg cells and in all tumor types studied, the level of CD25 expression in CD4+FoxP3+ Treg cells is also significantly higher than that in CD4+FoxP3− and CD8+ T cells26. This evidence concerns the gene CD8A and neoplasm.